Article
Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
Human gene therapy - 1 Jun 2007
Xiong Fu, Xiao Shaobo, Peng Funing, Zheng Hui, Yu Meijuan, Ruan Yechun, Li Wanyi, Shang Yanchang, Zhao Cuiping, Zhou Wenliang, Chen Huanchun, Chamberlain Jeffrey S, Fang Liurong, Zhang Cheng
Abstract excerpt
One of the obstacles to efficient vector-mediated gene therapy for Duchenne's muscular dystrophy (DMD) is its limited transduction efficiency. The VP22 tegument protein of herpes simplex virus type 1 (HSV-1) is able to cross biological membranes and translocate the VP22 fusion protein from transf...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
